Post a Free Blog

Submit A Press Release

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Action
Animation
ATP Tour (ATP)
Auto Racing
Baseball
Basketball
Boxing
Breaking News
Business
Business
Business Newsletter
Call of Duty (CALLOFDUTY)
Canadian Football League (CFL)
Car
Celebrity
Champions Tour (CHAMP)
Comedy
CONCACAF
Counter Strike Global Offensive (CSGO)
Crime
Defense of the Ancients (DOTA)
Documentary and Foreign
Drama
eSports
European Tour (EPGA)
Fashion
FIFA
FIFA Women’s World Cup (WWC)
FIFA World Cup (FIFA)
Fighting
Football
Formula 1 (F1)
Fortnite
Golf
Health
Hockey
Horror
IndyCar Series (INDY)
International Friendly (FRIENDLY)
Kids & Family
League of Legends (LOL)
LPGA
Madden
Major League Baseball (MLB)
Mixed Martial Arts (MMA)
MLS
Movie and Music
Movie Trailers
Mystery
NASCAR Cup Series (NAS)
National Basketball Association (NBA)
National Football League (NFL)
National Hockey League (NHL)
National Women's Soccer (NWSL)
NBA Development League (NBAGL)
NBA2K
NCAA Baseball (NCAABBL)
NCAA Basketball (NCAAB)
NCAA Football (NCAAF)
NCAA Hockey (NCAAH)
Olympic Mens (OLYHKYM)
Other
Other Sports
Overwatch
PGA
Politics
Premier League (PREM)
Romance
Sci-Fi
Science
Soccer
Sports
Sports
Technology
Tennis
Truck Series (TRUCK)
Ultimate Fighting Championship (UFC)
Uncategorized
US
Valorant
Women’s National Basketball Association (WNBA)
Women’s NCAA Basketball (WNCAAB)
World
World Cup Qualifier (WORLDCUP)
WTA Tour (WTA)
Xfinity (XFT)
XFL
0
-- Advertisement --spot_img
HomeBusinessThe Boeing Company’s Q2 Preview

The Boeing Company’s Q2 Preview

Add to Favorite
Added to Favorite


RBC Capital analysts provided their outlook on The Boeing Company (NYSE:BA) ahead of the company’s upcoming Q2 earnings, expected to be released on July 27.
While the strong June deliveries support confidence into the second half of the year, the analysts believe the focus remains on the MAX production and delivery outlook, the 787 resumption of deliveries, and the 2022 free cash flow guide.
The analysts believe investor expectations for full-year MAX deliveries are closer to 400, and supply chain issues remain a risk (engines, and other items). The analysts expect management to continue to highlight its transition to production rates of 31 per month and to prioritize stability in the MAX production line.
The analysts continue to like the stock near-term on potential catalysts and continue to model positive 2022 free cash flow. However, they reduced their price target on the company’s shares to $200 from $220 on lower multiples reflecting long-term headwinds.

Subscribe to get Latest News Updates

Latest News

You may like more
more

Thermo Fisher Scientific Reports Better Than Expected Q1 Results

Thermo Fisher Scientific (NYSE:TMO) announced its first-quarter earnings and...

Humana Drops 5 percent Despite Q1 Beat

Humana (NYSE:HUM) saw its shares drop by around 5%...